SCHEMBL6653339

SCHEMBL6653339

CCOC(=O)C1=C(O)CCc2cc(Br)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.44
SRD5A2 P31213 1/20 0.44
APAF1 O14727 1/20 0.40
SMAD3 P84022 1/20 0.40
ALOX5 P09917 4/20 0.40
PTGES O14684 1/20 0.40
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HPGD P15428 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648388 0.89 ALDH1A1 (0.42) APAF1SMAD3ALOX5PTGESALDH1A1
SCHEMBL4738338 0.85 SRD5A1 (0.43) SRD5A1SRD5A2APAF1SMAD3ALOX5
SCHEMBL10429668 0.81 SRD5A1 (0.61) SRD5A1SRD5A2APAF1SMAD3ALDH1A1
SCHEMBL6673635 0.80 HPGD (0.56) ALDH1A1SMN1; SMN2HPGDTDP1KDM4E
SCHEMBL7500172 0.78 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HPGDTDP1KDM4E
SCHEMBL21855441 0.76 CDC7 (0.42) ALDH1A1SMN1; SMN2HPGDTDP1KDM4E
SCHEMBL14710227 0.76 SRD5A1 (0.48) SRD5A1SRD5A2SMN1; SMN2L3MBTL1TDP2
SCHEMBL6648373 0.73 L3MBTL1 (0.42) SRD5A1SRD5A2ALDH1A1SMN1; SMN2HPGD
SCHEMBL23649905 0.73 CYP1A2 (0.40) SRD5A1SRD5A2ALOX5PTGESALDH1A1
SCHEMBL30121173 0.73 CYP1A2 (0.40) SRD5A1SRD5A2ALOX5PTGESALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6306865-B1 SYNTHASE INHIBITORS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-10-23 US disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
EP-0535034-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-04-07 EP disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed